PL2968467T3 - Preparaty o zmniejszonym utlenianiu - Google Patents
Preparaty o zmniejszonym utlenianiuInfo
- Publication number
- PL2968467T3 PL2968467T3 PL14776479T PL14776479T PL2968467T3 PL 2968467 T3 PL2968467 T3 PL 2968467T3 PL 14776479 T PL14776479 T PL 14776479T PL 14776479 T PL14776479 T PL 14776479T PL 2968467 T3 PL2968467 T3 PL 2968467T3
- Authority
- PL
- Poland
- Prior art keywords
- formulations
- reduced oxidation
- oxidation
- reduced
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39591—Stabilisation, fragmentation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2878—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
- C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/40—Immunoglobulins specific features characterized by post-translational modification
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/55—Fab or Fab'
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Lubricants (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361780852P | 2013-03-13 | 2013-03-13 | |
| US201361909850P | 2013-11-27 | 2013-11-27 | |
| PCT/US2014/026850 WO2014160497A1 (en) | 2013-03-13 | 2014-03-13 | Formulations with reduced oxidation |
| EP14776479.9A EP2968467B1 (en) | 2013-03-13 | 2014-03-13 | Formulations with reduced oxidation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2968467T3 true PL2968467T3 (pl) | 2020-10-19 |
Family
ID=51625443
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL14776479T PL2968467T3 (pl) | 2013-03-13 | 2014-03-13 | Preparaty o zmniejszonym utlenianiu |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP2968467B1 (pl) |
| JP (2) | JP6606059B2 (pl) |
| KR (2) | KR102317151B1 (pl) |
| CN (1) | CN105209058A (pl) |
| CA (2) | CA2904169C (pl) |
| DK (1) | DK2968467T3 (pl) |
| ES (1) | ES2808823T3 (pl) |
| HK (1) | HK1212613A1 (pl) |
| HR (1) | HRP20201161T1 (pl) |
| HU (1) | HUE049707T2 (pl) |
| LT (1) | LT2968467T (pl) |
| MX (1) | MX370416B (pl) |
| PL (1) | PL2968467T3 (pl) |
| PT (1) | PT2968467T (pl) |
| RS (1) | RS60534B1 (pl) |
| RU (2) | RU2019137020A (pl) |
| SI (1) | SI2968467T1 (pl) |
| WO (1) | WO2014160497A1 (pl) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ739788A (en) | 2015-08-18 | 2023-07-28 | Rakuten Medical Inc | Phthalocyanine dye conjugates and their storage |
| ES2992591T3 (en) | 2015-08-18 | 2024-12-16 | Rakuten Medical Inc | Compositions, combinations and related methods for photoimmunotherapy |
| SG11202011538RA (en) | 2018-06-01 | 2020-12-30 | Rakuten Medical Inc | Phthalocyanine dye conjugate compositions |
| IL280525B2 (en) | 2018-08-08 | 2024-11-01 | Genentech Inc | Use of tryptophan derivatives and l-methionine for protein formulation |
| WO2021186363A1 (en) * | 2020-03-20 | 2021-09-23 | Glaxosmithkline Intellectual Property Development Limited | Method for detecting polysorbates |
Family Cites Families (78)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| USRE30985E (en) | 1978-01-01 | 1982-06-29 | Serum-free cell culture media | |
| FR2413974A1 (fr) | 1978-01-06 | 1979-08-03 | David Bernard | Sechoir pour feuilles imprimees par serigraphie |
| US4419446A (en) | 1980-12-31 | 1983-12-06 | The United States Of America As Represented By The Department Of Health And Human Services | Recombinant DNA process utilizing a papilloma virus DNA as a vector |
| NZ201705A (en) | 1981-08-31 | 1986-03-14 | Genentech Inc | Recombinant dna method for production of hepatitis b surface antigen in yeast |
| US4601978A (en) | 1982-11-24 | 1986-07-22 | The Regents Of The University Of California | Mammalian metallothionein promoter system |
| US4560655A (en) | 1982-12-16 | 1985-12-24 | Immunex Corporation | Serum-free cell culture medium and process for making same |
| US4657866A (en) | 1982-12-21 | 1987-04-14 | Sudhir Kumar | Serum-free, synthetic, completely chemically defined tissue culture media |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| DD266710A3 (de) | 1983-06-06 | 1989-04-12 | Ve Forschungszentrum Biotechnologie | Verfahren zur biotechnischen Herstellung van alkalischer Phosphatase |
| US4767704A (en) | 1983-10-07 | 1988-08-30 | Columbia University In The City Of New York | Protein-free culture medium |
| US4965199A (en) | 1984-04-20 | 1990-10-23 | Genentech, Inc. | Preparation of functional human factor VIII in mammalian cells using methotrexate based selection |
| US4879231A (en) | 1984-10-30 | 1989-11-07 | Phillips Petroleum Company | Transformation of yeasts of the genus pichia |
| GB8516415D0 (en) | 1985-06-28 | 1985-07-31 | Celltech Ltd | Culture of animal cells |
| US4676980A (en) | 1985-09-23 | 1987-06-30 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Target specific cross-linked heteroantibodies |
| US6548640B1 (en) | 1986-03-27 | 2003-04-15 | Btg International Limited | Altered antibodies |
| US4927762A (en) | 1986-04-01 | 1990-05-22 | Cell Enterprises, Inc. | Cell culture medium with antioxidant |
| GB8610600D0 (en) | 1986-04-30 | 1986-06-04 | Novo Industri As | Transformation of trichoderma |
| DE68925971T2 (de) | 1988-09-23 | 1996-09-05 | Cetus Oncology Corp | Zellenzuchtmedium für erhöhtes zellenwachstum, zur erhöhung der langlebigkeit und expression der produkte |
| GB8823869D0 (en) | 1988-10-12 | 1988-11-16 | Medical Res Council | Production of antibodies |
| FI903489A0 (fi) | 1988-11-11 | 1990-07-10 | Medical Res Council | Ligander med en enda sektion, receptorer innehaollande naemnda ligander, foerfaranden foer deras framstaellning samt anvaendning av liganderna och receptorerna. |
| FR2646437B1 (fr) | 1989-04-28 | 1991-08-30 | Transgene Sa | Nouvelles sequences d'adn, leur application en tant que sequence codant pour un peptide signal pour la secretion de proteines matures par des levures recombinantes, cassettes d'expression, levures transformees et procede de preparation de proteines correspondant |
| EP0402226A1 (en) | 1989-06-06 | 1990-12-12 | Institut National De La Recherche Agronomique | Transformation vectors for yeast yarrowia |
| DE3920358A1 (de) | 1989-06-22 | 1991-01-17 | Behringwerke Ag | Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung |
| ES2096590T3 (es) | 1989-06-29 | 1997-03-16 | Medarex Inc | Reactivos biespecificos para la terapia del sida. |
| US5959177A (en) | 1989-10-27 | 1999-09-28 | The Scripps Research Institute | Transgenic plants expressing assembled secretory antibodies |
| ES2087997T3 (es) | 1990-01-12 | 1996-08-01 | Cell Genesys Inc | Generacion de anticuerpos xenogenicos. |
| US6075181A (en) | 1990-01-12 | 2000-06-13 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
| US6150584A (en) | 1990-01-12 | 2000-11-21 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
| AU8295491A (en) | 1990-06-29 | 1992-01-23 | Biosource Technologies Incorporated | Melanin production by transformed microorganisms |
| US5625126A (en) | 1990-08-29 | 1997-04-29 | Genpharm International, Inc. | Transgenic non-human animals for producing heterologous antibodies |
| US5545806A (en) | 1990-08-29 | 1996-08-13 | Genpharm International, Inc. | Ransgenic non-human animals for producing heterologous antibodies |
| ES2108048T3 (es) | 1990-08-29 | 1997-12-16 | Genpharm Int | Produccion y utilizacion de animales inferiores transgenicos capaces de producir anticuerpos heterologos. |
| US5661016A (en) | 1990-08-29 | 1997-08-26 | Genpharm International Inc. | Transgenic non-human animals capable of producing heterologous antibodies of various isotypes |
| US5633425A (en) | 1990-08-29 | 1997-05-27 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
| US5122469A (en) | 1990-10-03 | 1992-06-16 | Genentech, Inc. | Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins |
| DE69129154T2 (de) | 1990-12-03 | 1998-08-20 | Genentech, Inc., South San Francisco, Calif. | Verfahren zur anreicherung von proteinvarianten mit geänderten bindungseigenschaften |
| US5571894A (en) | 1991-02-05 | 1996-11-05 | Ciba-Geigy Corporation | Recombinant antibodies specific for a growth factor receptor |
| GB9114948D0 (en) | 1991-07-11 | 1991-08-28 | Pfizer Ltd | Process for preparing sertraline intermediates |
| EP0604580A1 (en) | 1991-09-19 | 1994-07-06 | Genentech, Inc. | EXPRESSION IN E. COLI OF ANTIBODY FRAGMENTS HAVING AT LEAST A CYSTEINE PRESENT AS A FREE THIOL, USE FOR THE PRODUCTION OF BIFUNCTIONAL F(ab') 2? ANTIBODIES |
| ATE181571T1 (de) | 1991-09-23 | 1999-07-15 | Medical Res Council | Methoden zur herstellung humanisierter antikörper |
| FI941572L (fi) | 1991-10-07 | 1994-05-27 | Oncologix Inc | Anti-erbB-2-monoklonaalisten vasta-aineiden yhdistelmä ja käyttömenetelmä |
| WO1993008829A1 (en) | 1991-11-04 | 1993-05-13 | The Regents Of The University Of California | Compositions that mediate killing of hiv-infected cells |
| US5667988A (en) | 1992-01-27 | 1997-09-16 | The Scripps Research Institute | Methods for producing antibody libraries using universal or randomized immunoglobulin light chains |
| DE69333807T2 (de) | 1992-02-06 | 2006-02-02 | Chiron Corp., Emeryville | Marker für krebs und biosynthetisches bindeprotein dafür |
| DE69308573T2 (de) | 1992-08-17 | 1997-08-07 | Genentech Inc | Bispezifische immunoadhesine |
| EP1005870B1 (en) | 1992-11-13 | 2009-01-21 | Biogen Idec Inc. | Therapeutic application of chimeric antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma |
| US5789199A (en) | 1994-11-03 | 1998-08-04 | Genentech, Inc. | Process for bacterial production of polypeptides |
| US5840523A (en) | 1995-03-01 | 1998-11-24 | Genetech, Inc. | Methods and compositions for secretion of heterologous polypeptides |
| US5731168A (en) | 1995-03-01 | 1998-03-24 | Genentech, Inc. | Method for making heteromultimeric polypeptides |
| US5641870A (en) | 1995-04-20 | 1997-06-24 | Genentech, Inc. | Low pH hydrophobic interaction chromatography for antibody purification |
| US5869046A (en) | 1995-04-14 | 1999-02-09 | Genentech, Inc. | Altered polypeptides with increased half-life |
| EP0822830B1 (en) | 1995-04-27 | 2008-04-02 | Amgen Fremont Inc. | Human anti-IL-8 antibodies, derived from immunized xenomice |
| CA2219486A1 (en) | 1995-04-28 | 1996-10-31 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
| RU2134120C1 (ru) * | 1995-06-26 | 1999-08-10 | Безруков Михаил Васильевич | Средство для стабилизации пептидной связи в белковом препарате |
| CA2264177C (en) | 1996-08-30 | 2015-03-17 | Upfront Chromatography A/S | Isolation of immunoglobulins |
| EP2305027B1 (en) | 1996-12-03 | 2014-07-02 | Amgen Fremont Inc. | Transgenic mammals having human Ig loci including plural VH and Vkappa regions and antibodies produced therefrom |
| US20080318254A9 (en) | 1997-03-10 | 2008-12-25 | The Regents Of The University Of California | PSCA antibodies and hybridomas producing them |
| US20020173629A1 (en) | 1997-05-05 | 2002-11-21 | Aya Jakobovits | Human monoclonal antibodies to epidermal growth factor receptor |
| US6040498A (en) | 1998-08-11 | 2000-03-21 | North Caroline State University | Genetically engineered duckweed |
| US6610833B1 (en) | 1997-11-24 | 2003-08-26 | The Institute For Human Genetics And Biochemistry | Monoclonal human natural antibodies |
| AU760562B2 (en) | 1997-12-05 | 2003-05-15 | Scripps Research Institute, The | Humanization of murine antibody |
| JP2000247903A (ja) * | 1999-03-01 | 2000-09-12 | Chugai Pharmaceut Co Ltd | 長期安定化製剤 |
| DK1167537T3 (da) | 1999-03-30 | 2008-11-10 | Japan Tobacco Inc | Fremgangsmåde til fremstilling af et monoklonalt antistof |
| ATE464062T1 (de) * | 1999-10-04 | 2010-04-15 | Novartis Vaccines & Diagnostic | Stabilisierte flüssige pharmazeutische zusammensetzung enthaltend tfpi |
| DE60022369T2 (de) | 1999-10-04 | 2006-05-18 | Medicago Inc., Sainte Foy | Verfahren zur regulation der transkription von fremden genen in gegenwart von stickstoff |
| US7125978B1 (en) | 1999-10-04 | 2006-10-24 | Medicago Inc. | Promoter for regulating expression of foreign genes |
| JP2001165858A (ja) * | 1999-12-06 | 2001-06-22 | Bunshi Biophotonics Kenkyusho:Kk | ５−アルコキシインドール類の測定方法及び装置 |
| EP1463522A4 (en) | 2001-05-16 | 2005-04-13 | Einstein Coll Med | HUMAN ANTIPNEUMOKOKKEN ANTIBODIES OF NON-THUMBAN ANIMALS |
| PL217752B1 (pl) | 2001-08-23 | 2014-08-29 | Genmab As | Izolowane ludzkie przeciwciało monoklonalne wobec IL-15 lub jego fragment wiążący antygen i związane z nimi hybrydoma, kompozycja farmaceutyczna oraz zastosowania medyczne |
| US20050276823A1 (en) * | 2002-07-12 | 2005-12-15 | Cini John K | Methods and compositions for preventing oxidative degradation of proteins |
| WO2004065547A2 (en) | 2003-01-17 | 2004-08-05 | The Research Foundation Of The State University Of New York | Pancreatic cancer associated antigen, antibody thereto, and diagnostic and treatment methods |
| US20060104968A1 (en) | 2003-03-05 | 2006-05-18 | Halozyme, Inc. | Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminogly ycanases |
| US7871607B2 (en) | 2003-03-05 | 2011-01-18 | Halozyme, Inc. | Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases |
| MXPA05012571A (es) | 2003-05-21 | 2006-02-08 | Medarex Inc | Anticuerpos monoclonales humanos contra el antigeno protector de bacillus anthracis. |
| CN101074208A (zh) * | 2007-06-29 | 2007-11-21 | 方炳良 | 吲哚衍生物的制备方法 |
| RU2414237C2 (ru) * | 2008-04-30 | 2011-03-20 | Государственное образовательное учреждение высшего профессионального образования "Удмуртский государственный университет" | Модификация альбумина совиалем как способ повышения его стабильности для производства фармацевтического биопрепарата альбумина в комплексе с гентамицином или стимаденом |
| CA2734275A1 (en) * | 2008-09-10 | 2010-03-18 | Genentech, Inc. | Compositions and methods for the prevention of oxidative degradation of proteins |
| MY199135A (en) * | 2013-03-13 | 2023-10-17 | Genentech Inc | Formulations with reduced oxidation |
-
2014
- 2014-03-13 CA CA2904169A patent/CA2904169C/en active Active
- 2014-03-13 SI SI201431625T patent/SI2968467T1/sl unknown
- 2014-03-13 KR KR1020217009995A patent/KR102317151B1/ko active Active
- 2014-03-13 WO PCT/US2014/026850 patent/WO2014160497A1/en not_active Ceased
- 2014-03-13 MX MX2015011433A patent/MX370416B/es active IP Right Grant
- 2014-03-13 EP EP14776479.9A patent/EP2968467B1/en active Active
- 2014-03-13 HR HRP20201161TT patent/HRP20201161T1/hr unknown
- 2014-03-13 RU RU2019137020A patent/RU2019137020A/ru unknown
- 2014-03-13 CA CA3135558A patent/CA3135558A1/en not_active Abandoned
- 2014-03-13 DK DK14776479.9T patent/DK2968467T3/da active
- 2014-03-13 PL PL14776479T patent/PL2968467T3/pl unknown
- 2014-03-13 KR KR1020157027939A patent/KR102238379B1/ko active Active
- 2014-03-13 PT PT147764799T patent/PT2968467T/pt unknown
- 2014-03-13 HU HUE14776479A patent/HUE049707T2/hu unknown
- 2014-03-13 ES ES14776479T patent/ES2808823T3/es active Active
- 2014-03-13 JP JP2016502264A patent/JP6606059B2/ja active Active
- 2014-03-13 RS RS20200848A patent/RS60534B1/sr unknown
- 2014-03-13 LT LTEP14776479.9T patent/LT2968467T/lt unknown
- 2014-03-13 HK HK16100589.9A patent/HK1212613A1/zh unknown
- 2014-03-13 RU RU2015143549A patent/RU2707550C2/ru active
- 2014-03-13 CN CN201480027210.8A patent/CN105209058A/zh active Pending
-
2019
- 2019-05-08 JP JP2019088239A patent/JP2019167349A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN105209058A (zh) | 2015-12-30 |
| RU2015143549A (ru) | 2017-04-20 |
| CA2904169A1 (en) | 2014-10-02 |
| RU2019137020A (ru) | 2021-01-14 |
| MX370416B (es) | 2019-12-10 |
| EP2968467A4 (en) | 2016-09-21 |
| DK2968467T3 (da) | 2020-08-10 |
| KR102238379B1 (ko) | 2021-04-09 |
| CA2904169C (en) | 2021-12-07 |
| KR102317151B1 (ko) | 2021-10-26 |
| RU2707550C2 (ru) | 2019-11-27 |
| KR20210040190A (ko) | 2021-04-12 |
| CA3135558A1 (en) | 2014-10-02 |
| PT2968467T (pt) | 2020-07-28 |
| MX2015011433A (es) | 2016-04-27 |
| ES2808823T3 (es) | 2021-03-02 |
| RS60534B1 (sr) | 2020-08-31 |
| JP6606059B2 (ja) | 2019-11-13 |
| EP2968467B1 (en) | 2020-06-03 |
| HUE049707T2 (hu) | 2020-11-30 |
| HK1212613A1 (zh) | 2016-06-17 |
| HRP20201161T1 (hr) | 2020-11-13 |
| BR112015022475A8 (pt) | 2019-11-26 |
| LT2968467T (lt) | 2020-08-25 |
| SI2968467T1 (sl) | 2020-11-30 |
| BR112015022475A2 (pt) | 2017-07-18 |
| JP2019167349A (ja) | 2019-10-03 |
| KR20150130396A (ko) | 2015-11-23 |
| JP2016513667A (ja) | 2016-05-16 |
| EP2968467A1 (en) | 2016-01-20 |
| WO2014160497A1 (en) | 2014-10-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB201319791D0 (en) | Formulations | |
| ZA201906057B (en) | Formulations with reduced oxidation | |
| GB201319792D0 (en) | Formulations | |
| IL245420B (en) | New formulations | |
| GB201321922D0 (en) | Constructions | |
| AU353644S (en) | Stamphousing | |
| HUE049707T2 (hu) | Csökkent oxidációjú kiszerelések | |
| GB201322948D0 (en) | Improved formulation | |
| GB201311130D0 (en) | Greensleeves I | |
| GB201306901D0 (en) | Combination | |
| GB201302952D0 (en) | Easily fitted longerie | |
| GB201311464D0 (en) | Concept Eleven | |
| GB201317353D0 (en) | Ed | |
| AU349000S (en) | Caster | |
| GB201304305D0 (en) | E C Trackograph | |
| AU353328S (en) | Kettlebell | |
| AU353331S (en) | Kettlebell | |
| AU353325S (en) | Kettlebell | |
| AU353329S (en) | Kettlebell | |
| AU353330S (en) | Kettlebell | |
| GB201318451D0 (en) | W/C Sani-vent | |
| AP00812S1 (en) | Stumbelbloc | |
| AU2013231V (en) | Bonsca7200 Scaevola aemula | |
| AU353341S (en) | Playsuit | |
| AU354283S (en) | Playsuit |